Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | GMNN | O75496 | 1/20 | 0.39 |
| ▸ | PPM1B | O75688 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.39 |
| ▸ | TFPI2 | P48307 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | PPP5C | P53041 | 1/20 | 0.39 |
| ▸ | PPP1CA | P62136 | 1/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | THPO | P40225 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3764057 | 1.00 | KDM4E (0.39) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL23895076 | 1.00 | KDM4E (0.39) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL20646727 | 0.97 | KDM4E (0.37) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL10680562 | 0.94 | KDM4E (0.39) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL23380386 | 0.91 | KDM4E (0.33) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL19485747 | 0.91 | ALDH1A1 (0.36) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL18700017 | 0.88 | KDM4E (0.42) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL20428057 | 0.88 | KDM4E (0.42) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL3721811 | 0.88 | KDM4E (0.42) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL2709834 | 0.88 | KDM4E (0.42) | KDM4EGMNNPPM1BLMNAPPP1CC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1149836-B1 | Polynalbuphine derivatives | HU OLIVER YOA PU (TW) | 2003-02-26 | — | — | EP | claimed |
| EP-1149836-A1 | Polynalbuphine derivatives | Hu, Oliver Yoa-Pu (TW) | 2001-10-31 | — | — | EP | claimed |
| US-5017679-A | Polyesters terminated with carboxycyclohexanecarboxylate groups | EASTMAN KODAK COMPANY (US) | 1991-05-21 | — | — | US | claimed |
| US-12637405-B2 | Integrated process for generating acid anhydrides | CLEANTECH BUILDING MATERIALS PLC (GB) | 2026-05-26 | — | — | US | disclosed |
| US-20250304521-A1 | PROCESS FOR GENERATING ACID ANHYDRIDES | CLEANTECH BUILDING MATERIALS PLC (GB) | 2025-10-02 | — | — | US | disclosed |
| US-12358860-B2 | Process for generating acid anhydrides | CLEANTECH BUILDING MATERIALS PLC (GB) | 2025-07-15 | — | — | US | disclosed |
| CN-118852152-A | Pyridazinone compound and preparation method and application thereof | 国科大杭州高等研究院 | 2024-10-29 | — | — | CN | disclosed |
| WO-2024097923-A1 | INTEGRATED PROCESS FOR GENERATING ACID ANHYDRIDES | HYCONIX, INC. (US) | 2024-05-10 | — | — | WO | disclosed |
| CN-117987189-A | Modified castor oil diesel antiwear agent, preparation method thereof and diesel composition | 中国石油化工股份有限公司 | 2024-05-07 | — | — | CN | disclosed |
| EP-4334280-A1 | INTEGRATED PROCESS FOR GENERATING ACID ANHYDRIDES | Hyconix, Inc. (US) | 2024-03-13 | — | — | EP | disclosed |
| CN-117677602-A | Integrated process for producing anhydrides | 纮康公司 | 2024-03-08 | — | — | CN | disclosed |
| US-5017679-A | Polyesters terminated with carboxycyclohexanecarboxylate groups | EASTMAN KODAK COMPANY (US) | 1991-05-21 | — | — | US | disclosed |
| US-4985490-A | EMULSION REACTION, SURFACTANT TO PREVENT AGGLOMERATION, PIGMENT INCORPORATED DURING POLYMERIZATION | BAYER AKTIENGESELLSCHAFT (DE) | 1991-01-15 | — | — | US | disclosed |
| EP-0394789-A1 | Continuous process for the production of powdered polyisocyanate addition products and the powders produced therefrom | BAYER AG (DE) | 1990-10-31 | — | — | EP | disclosed |
| EP-0392285-A2 | Method of direct manufacture of pigmented polyurethane powder | BAYER AG (DE) | 1990-10-17 | — | — | EP | disclosed |
| US-4940750-A | Continuous process for the production of powdered polyisocyanate addition products and the powders produced therefrom | BAYER AKTIENGESELLSCHAFT (DE) | 1990-07-10 | — | — | US | disclosed |
| EP-0309544-A1 | PSYCHOTROPIC BICYCLIC IMIDES. | AMERICAN HOME PROD (US) | 1989-04-05 | — | — | EP | disclosed |
| WO-1988007530-A1 | PSYCHOTROPIC BICYCLIC IMIDES | AMERICAN HOME PRODUCTS CORPORATION (US) | 1988-10-06 | — | — | WO | disclosed |
| US-4748240-A | Psychotropic bicyclic imides | AMERICAN HOME PRODUCTS CORPORATION (US) | 1988-05-31 | — | — | US | disclosed |
| EP-0268369-A1 | Bridged bicyclic imides as anxiolytics and antidepressants | PFIZER INC. (US) | 1988-05-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250304521-A1 | PROCESS FOR GENERATING ACID ANHYDRIDES | CA1, CA9, CA6 | KDM4E 3120/4885GMNN 793/4885PPM1B 1392/4885 |
| US-12358860-B2 | Process for generating acid anhydrides | CA1, CA9, CA6 | KDM4E 3120/4885GMNN 793/4885PPM1B 1392/4885 |
| US-12637405-B2 | Integrated process for generating acid anhydrides | GRHPR, GCDH, OGDH | KDM4E 2588/4885GMNN 1254/4885PPM1B 3209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.